Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             120 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Author Index 2008
 18 Supplement 1 p. s95-s98
nvt p.
 artikel
2 Calendar of Meetings of the European College ofNeuropsychopharmacology 2008
 18 Supplement 1 p. 78-
1 p.
 artikel
3 C.15.01 An important aspect of AD: behavioural symptoms Robert, P.
 2008
 18 Supplement 1 p. S604-
1 p.
 artikel
4 Cannabinoid receptor 1 (CNR1) gene: Impact on antidepressant treatment response and emotion processing in Major Depression Domschke, Katharina
 2008
 18 Supplement 1 p. 751-759
9 p.
 artikel
5 C.10.03 Building a new chapter Kane, J.
 2008
 18 Supplement 1 p. S598-S599
2 p.
 artikel
6 C.09.03 Circadin–anew melatonin treatment Wade, A.
 2008
 18 Supplement 1 p. S597-S598
2 p.
 artikel
7 C.05.02 Clinical research update – focus on Flurizan Green, R.
 2008
 18 Supplement 1 p. S593-
1 p.
 artikel
8 C.19.04 Making treatment decisions in depression: balancing efficacy and tolerability among contemporary antidepressant treatment options Bauer, M.
 2008
 18 Supplement 1 p. S610-
1 p.
 artikel
9 C.19.01 Non serotonergic circuits involved in depression Artigas, F.
 2008
 18 Supplement 1 p. S609-
1 p.
 artikel
10 C.24.02 Preclinical profiling of antipsychotics – new data and implication on clinical outcome Arnt, J.A.
 2008
 18 Supplement 1 p. S615-
1 p.
 artikel
11 Distinct contributions of dopamine receptors in the nucleus accumbens core or shell to established cocaine reinforcement under a second-order schedule Di Ciano, Patricia
 2008
 18 Supplement 1 p. 888-896
9 p.
 artikel
12 E.03.03 ECT maintenance therapy in recurrent depression Bolwig, T.
 2008
 18 Supplement 1 p. S200-
1 p.
 artikel
13 E.05.02 The effects of migration: cultural aspects in mental health care Haasen, C.
 2008
 18 Supplement 1 p. S201-
1 p.
 artikel
14 Factors triggering abolishment of benzodiazepines effects in the four-plate test–retest in mice Petit-Demoulière, B.
 2008
 18 Supplement 1 p. 41-47
7 p.
 artikel
15 Increased sensitivity to antidepressants of D3 dopamine receptor-deficient mice in the forced swim test (FST) Leggio, Gian Marco
 2008
 18 Supplement 1 p. 271-277
7 p.
 artikel
16 α1-Noradrenergic system role in increased motivation for cocaine intake in rats with prolonged access Wee, Sunmee
 2008
 18 Supplement 1 p. 303-311
9 p.
 artikel
17 P.3.a.004 Aggressive behaviour during acute mania: a cross-sectional study with 173 different manic patients González-Pinto, A.
 2008
 18 Supplement 1 p. S387-
1 p.
 artikel
18 P.8.a.008 Basal cortisol release and variability in relation to lipoproteins and obesity in patients with mood and anxiety disorders Veen, G.
 2008
 18 Supplement 1 p. S571-
1 p.
 artikel
19 P.1.21 Aberrant hippocampal expression of immune signalling-related genes in the rodent models of schizophrenia Lukasz, B.
 2008
 18 Supplement 1 p. s18-s19
nvt p.
 artikel
20 P.2.a.017 Comparison of the psychometric properties of the self-rating scales hospital anxiety and depression scale (HADS) and patient health questionnaire (PHQ-9) Hansson, M.
 2008
 18 Supplement 1 p. S302-
1 p.
 artikel
21 P.4.a.007 Contingent negative variation abnormalities in posttraumatic stress disorder Papart, P.
 2008
 18 Supplement 1 p. S481-S482
2 p.
 artikel
22 P.8.a.022 Do European patients with fibromyalgia respond differently than others to pregabalin? A 14-week monotherapy trial Pauer, L.
 2008
 18 Supplement 1 p. S579-S580
2 p.
 artikel
23 P.1.a.011 Effect of angiotension-converting enzyme gene i/d polymorphism on training- and detraining-induced changes in adiposity Yi, J.S.
 2008
 18 Supplement 1 p. S208-S209
2 p.
 artikel
24 P.3.a.007 FOXP2 gene possibly associated with Korean schizophrenic patients Jung, S.M.
 2008
 18 Supplement 1 p. S389-
1 p.
 artikel
25 P.1.a.002 Glial cell-derived neurotrophic family (GFR) alpha 1 receptor polymorphisms and weight change during clozapine treatment Souza, R.
 2008
 18 Supplement 1 p. S203-S204
2 p.
 artikel
26 P.4.a.010 Integrated treatment model for panic disorder. A 3-year follow-up clinical study Vigano', C.
 2008
 18 Supplement 1 p. S483-
1 p.
 artikel
27 P.6.a.001 Personality trait of alcoholic patients using the Korean version of temperament and character inventory Lee, J.S.
 2008
 18 Supplement 1 p. S519-
1 p.
 artikel
28 P.2.a.034 Plasma dehydroepiandrosterone sulphate (DHEAS) and cortisol in patients with mood disorders Camardese, G.
 2008
 18 Supplement 1 p. S311-S312
2 p.
 artikel
29 P.1.16 A putative mechanism for interleukin-1- associated nociception via astrocytic glutamate transporters modulation Ziv, N.
 2008
 18 Supplement 1 p. s14-s15
nvt p.
 artikel
30 P.2.12 A role for the opioid system in endocannabinoid-mediated fearconditioned analgesia in rats Butler, R.K.
 2008
 18 Supplement 1 p. s46-s47
nvt p.
 artikel
31 P.1.15 Association of dystrobrevin binding protein 1 gene (DTNBP1) in a bipolar case-control study (BACCS) Gaysina, D.
 2008
 18 Supplement 1 p. s13-s14
nvt p.
 artikel
32 P.8.a.005 The effect of ondansetron, a 5-HT3 receptor antagonist, in chronic fatigue syndrome: a randomized controlled trial The, G.K.H.
 2008
 18 Supplement 1 p. S569-
1 p.
 artikel
33 P.2.a.007 Variations in tryptophan hydroxylase 2 are associated with elevated risk for metabolic syndrome in depression Kloiber, S.
 2008
 18 Supplement 1 p. S296-
1 p.
 artikel
34 P.1.b.004 Activation of thalamo-cortical circuits by phencyclidine, reversal by clozapine Santana, N.
 2008
 18 Supplement 1 p. S218-S219
2 p.
 artikel
35 P.6.b.002 Cannabinoid CB1 receptor protein expression in postmortem brain of suicidal and non-suicidal alcoholic subjects Erdozain, A.M.
 2008
 18 Supplement 1 p. S527-S528
2 p.
 artikel
36 P.2.b.014 Chronic stress in rats as model for depression: effects of citalopram on expression of TPH isoforms 1 and 2 Abumaria, N.
 2008
 18 Supplement 1 p. S320-S321
2 p.
 artikel
37 P.1.b.001 Clinical characteristics and heart rate variability in patients comorbid panic disorder with major depressive disorder Choi, Y.
 2008
 18 Supplement 1 p. S217-
1 p.
 artikel
38 P.3.b.001 Clinical improvement in schizophrienia is associated with a normalization of elevated serum S100B and increased sRAGE Steiner, J.
 2008
 18 Supplement 1 p. S397-S398
2 p.
 artikel
39 P.2.b.012 Depressive coping style predicts the relationship between cortisol responses and stress experience Netter, P.
 2008
 18 Supplement 1 p. S319-S320
2 p.
 artikel
40 P.4.b.007 Interactions between serotonin 5-HT3 and cannabinoid CB-1 receptor function in the control of anxiety in mice Mikics, E.
 2008
 18 Supplement 1 p. S490-
1 p.
 artikel
41 P.2.b.015 Lu AA21004: a novel potential treatment for mood disorders Moore, N.
 2008
 18 Supplement 1 p. S321-
1 p.
 artikel
42 P.4.b.009 Relationship of panic and agoraphobia: rethinking of a diagnostic concept? Nocon, A.
 2008
 18 Supplement 1 p. S491-S492
2 p.
 artikel
43 P.4.b.001 Role of transient receptor potential vanilloid type 1 channels in brain regions related to anxiety in rats Bertoglio, L.J.
 2008
 18 Supplement 1 p. S487-
1 p.
 artikel
44 P.2.b.009 The effect of fluvoxamine on akt-1 phosphorylation and total akt-1 protein levels by immunoblotting in PC12 neuronal cells Nakano, M.
 2008
 18 Supplement 1 p. S317-S318
2 p.
 artikel
45 P.5.b.002 The neuroprotective effect of apoliporotein E on the oxidative stress in alzheimer's disease Cho, W.
 2008
 18 Supplement 1 p. S509-
1 p.
 artikel
46 P.1.c.018 β1-adrenergic receptor activation evokes a long-lasting increase in hippocampal theta (4−15Hz) rhythm in vitro Haggerty, D.
 2008
 18 Supplement 1 p. S230-
1 p.
 artikel
47 P.3.c.006 Cognitive function and antipsychotic treatment in chronic schizophrenia Kalwa, A.
 2008
 18 Supplement 1 p. S407-S408
2 p.
 artikel
48 P.1.c.039 Concomitant blockade of 5-HT1a receptor and 5-HT transporter: use of Hunter serotonin toxicity criteria in a clinical pharmacology study Parks, V.
 2008
 18 Supplement 1 p. S241-S242
2 p.
 artikel
49 P.6.c.003 Effects of cannabis use on cognitive brain function in adolescents: short-term memory, long-term consequences? Jager, G.
 2008
 18 Supplement 1 p. S533-
1 p.
 artikel
50 P.7.c.001 Effects of variable wear times on transdermal methylphenidate in attention-deficit/hyperactivity disorder López, F.A.
 2008
 18 Supplement 1 p. S561-S562
2 p.
 artikel
51 P.3.c.048 Evolution of neuroleptic-induced extrapyramidal syndromes in Spain Gonzalez Irizar, O.
 2008
 18 Supplement 1 p. S431-
1 p.
 artikel
52 P.3.c.031 Evolution of psychotic inpatients treated with long-acting injectable risperidone after 1000 days of follow-up Nieto, E.
 2008
 18 Supplement 1 p. S421-S422
2 p.
 artikel
53 P.1.c.029 Experimental research on the effects of dopaminergic receptor antagonists in cutaneous and visceral pain models Sacara, I.
 2008
 18 Supplement 1 p. S236-
1 p.
 artikel
54 P.2.c.008 Fading of the inhibition of CYP2D6 after paroxetine treatment discontinuation Zourkova, A.
 2008
 18 Supplement 1 p. S328-S329
2 p.
 artikel
55 P.2.c.025 Long-term treatment with agomelatine: prevention of relapse in patients with Major Depressive Disorder over 10 months Goodwin, G.M.
 2008
 18 Supplement 1 p. S338-S339
2 p.
 artikel
56 P.3.c.045 Management of expectations, satisfaction and well-being of psychotic patients, their families and caregivers (alliance) Ortiz, M.F. Bravo
 2008
 18 Supplement 1 p. S429-S430
2 p.
 artikel
57 P.1.c.015 1-Methyl-1,2,3,4-tetrahydroisoquinoline antagonizes behavioral and neurochemical effects produced by MK-801 in rat Antkiewicz-Michaluk, L.
 2008
 18 Supplement 1 p. S228-S229
2 p.
 artikel
58 P.1.c.012 Modulators of inhibitory synaptic transmission in mouse somatosensory cortex Kruglikov, I.
 2008
 18 Supplement 1 p. S226-S227
2 p.
 artikel
59 P.3.c.016 Predictors of response to antipsychotics and/or associations in schizoaffective disorder Chirita, A.
 2008
 18 Supplement 1 p. S413-
1 p.
 artikel
60 P.3.c.003 Risperidone in treatment of delusional disorders Zivkovic, N.
 2008
 18 Supplement 1 p. S405-S406
2 p.
 artikel
61 P.6.c.006 Substance abuse and addiction profile in 6600 patients admitted at a psychiatric emergency room Minner, P.
 2008
 18 Supplement 1 p. S535-
1 p.
 artikel
62 P.2.c.022 Superior antidepressant efficacy of agomelatine versus sertraline: a randomised, double-blind study Kasper, S.
 2008
 18 Supplement 1 p. S336-S337
2 p.
 artikel
63 P.3.c.062 32 weeks follow-up of effectiveness of schizophrenia treatment with olanzapine Krzystanek, M.
 2008
 18 Supplement 1 p. S439-S440
2 p.
 artikel
64 P.3.d.002 Characterization of aripiprazole partial agonist activity at human dopamine D3 receptors Tadori, Y.
 2008
 18 Supplement 1 p. S449-
1 p.
 artikel
65 P.3.d.016 Effects of asenapine on prefrontal NMDA receptor-mediated transmission: involvement of dopamine D1 receptors Svensson, T.H.
 2008
 18 Supplement 1 p. S457-
1 p.
 artikel
66 P.2.d.003 Excitatory effect of the atypical antidepressant tianeptine in the rat hippocampus: in vitro study Kapus, G.
 2008
 18 Supplement 1 p. S346-S347
2 p.
 artikel
67 P.2.d.017 Ketanzerine modulates expression of 5-HT2A/2C- and 17b-estradiol receptors mRNAs in female rats in forced swim test Fedotova, J.
 2008
 18 Supplement 1 p. S354-S355
2 p.
 artikel
68 P.3.d.004 1-Methyl-1,2,3,4-tetrahydroisoquinoline (1MeTIQ) inhibits effects of MK-801 in rat frontal cortex: in vivo microdialysis study Wasik, A.
 2008
 18 Supplement 1 p. S450-
1 p.
 artikel
69 P.6.d.007 Regulation of phosphorylated forms of the proteins FADD, MAPKs, and PEA-15 in the prefrontal cortex of human opioid abusers Ramos-Miguel, A.
 2008
 18 Supplement 1 p. S543-
1 p.
 artikel
70 P.3.d.001 SSR103800, an inhibitor of the GlyT-1 reverses hyperactivity in glutamatergic but not dopaminergic models in mice Boulay, D.
 2008
 18 Supplement 1 p. S448-S449
2 p.
 artikel
71 P.1.d.002 The effect of chlordiazepoxide on reward reduction-induced decrease of operant performance Nikiforuk, A.
 2008
 18 Supplement 1 p. S249-S250
2 p.
 artikel
72 P.1.d.005 The effects of topiramate on spatial memory and movement co-ordination in rats Nowakowska, E.
 2008
 18 Supplement 1 p. S251-S252
2 p.
 artikel
73 P.3.d.019 The influence of neuroleptic medication on several oxidative stress markers in schizophrenic patients Cozman, D.
 2008
 18 Supplement 1 p. S459-
1 p.
 artikel
74 P.3.e.020 Acute agitation, psychotic symptoms and use of neuroleptics: a study of pre-hospital management Tonn, P.
 2008
 18 Supplement 1 p. S472-S473
2 p.
 artikel
75 P.2.e.019 Adult attention-deficit hyperactivity disorder in bipolar disorder Tamam, L.
 2008
 18 Supplement 1 p. S369-S370
2 p.
 artikel
76 P.2.e.005 Anticonvulsant treatment, B12 plasma levels and mood disorders Neroutsos, E.
 2008
 18 Supplement 1 p. S361-S362
2 p.
 artikel
77 P.6.e.005 Caffeine intake, intoxication, withdrawal and dependence in psychiatric patients and in control subjects Paggini, R.
 2008
 18 Supplement 1 p. S551-
1 p.
 artikel
78 P.1.e.001 Coexpression of serotonin transporter and serotonin-1A receptor in human brain: a multitracer PET study Savli, M.
 2008
 18 Supplement 1 p. S259-
1 p.
 artikel
79 P.4.e.005 Efficacy and tolerability of extended release quetiapine fumarate monotherapy in the treatment of GAD Merideth, C.
 2008
 18 Supplement 1 p. S499-S500
2 p.
 artikel
80 P.1.04 Effects of repeated treatment of phencyclidine in cognition, emotional activity and gene expression in C57BL/6J mice Beraki, S.
 2008
 18 Supplement 1 p. s5-
1 p.
 artikel
81 P.1.e.015 Frontal serotonin-1A receptor distribution is associated with aggression scores in healthy subjects Witte, A.V.
 2008
 18 Supplement 1 p. S267-S268
2 p.
 artikel
82 P.1.e.018 Hypoperfusion and reduced blood-oxygen level dependent activation of the fusiform face area patients with delusional misidentification syndrome Müller, T.
 2008
 18 Supplement 1 p. S269-S270
2 p.
 artikel
83 P.2.e.008 Low serum dehydroepiandrosteronesulphate is associated with interpersonal aggression in males with Bipolar 1 disorder Johansson, A.G.M.
 2008
 18 Supplement 1 p. S363-S364
2 p.
 artikel
84 P.3.e.010 Perception of self-influence on the course of schizophrenia and adherence to antipsychotics Kokoszka, A.
 2008
 18 Supplement 1 p. S467-
1 p.
 artikel
85 P.2.e.002 Psychoeducational intervention in families of patients with bipolar disorder González-Pinto, A.
 2008
 18 Supplement 1 p. S360-
1 p.
 artikel
86 P.5.f.001 Dietary restriction effects on age induced changes in APP, PS-1 and ADAM mRNA expression Djordjevic, A. Mladenovic
 2008
 18 Supplement 1 p. S518-S519
2 p.
 artikel
87 P.4.f.002 Electroretinogram B wave amplitude, dopaminergic system and panic disorder Bossini, L.
 2008
 18 Supplement 1 p. S501-
1 p.
 artikel
88 P.3.f.006 Neonatal administration of HIV-1 proteins alters behaviour and NMDA receptor binding in the adult rat brain Tejkalová, H.B.
 2008
 18 Supplement 1 p. S477-
1 p.
 artikel
89 P.6.f.003 Neurosteroid dehydroepiandrosterone sulphate (DHEAS) is rewarding and alters the rewarding effect of cocaine Zajda, Z.E.
 2008
 18 Supplement 1 p. S553-
1 p.
 artikel
90 P.1.g.009 Attentional bias towards health-threat information in chronic fatigue syndrome Hou, R.
 2008
 18 Supplement 1 p. S278-
1 p.
 artikel
91 P.2.g.011 Significant effect of sertraline on dopamine transporter (DAT) in major depression measured by b-CIT SPECT Szabó, Z.
 2008
 18 Supplement 1 p. S379-
1 p.
 artikel
92 Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the glycine transporter-1 inhibitor NFPS and d-serine Hashimoto, Kenji
 2008
 18 Supplement 1 p. 414-421
8 p.
 artikel
93 P.1.35 Hippocampal expression of BDNF is involved in the behavioral effects of the β3 adrenoceptor agonist, SR58611A Tamburella, A.
 2008
 18 Supplement 1 p. s29-s30
nvt p.
 artikel
94 P.1.h.002 The effects of race and other factors on diagnosis in psychiatric inpatients: a retrospective chart review Choi, M.
 2008
 18 Supplement 1 p. S286-S287
2 p.
 artikel
95 P.2.29 Hyperactivity and response to amphetamine in SynGAP heterozygous knockout mice Muhia, M.
 2008
 18 Supplement 1 p. s60-
1 p.
 artikel
96 P.1.i.001 Chronic citalopram treatment counteracts kainic acid induced increase in PSA-NCAM expressing cells and avoids migration Jaako, K.
 2008
 18 Supplement 1 p. S288-
1 p.
 artikel
97 P.1.i.004 GABA transporter 1 (GAT1) specifically binds to ubiquitins in the mouse brain Lee, S.K.
 2008
 18 Supplement 1 p. S290-
1 p.
 artikel
98 PL.01.01 Molecular mechanisms of learning and memory Collingridge, G.L.
 2008
 18 Supplement 1 p. S153-
1 p.
 artikel
99 P.2.26 Significance of a genetically de.ned GABAA-receptor de.cit on breathing behaviour: relevance to respiratory panic Masneuf, S.
 2008
 18 Supplement 1 p. s57-s58
nvt p.
 artikel
100 P.1.18 The genetic basis of individual vulnerability to chronic stress: role of AMPA receptors Schmidt, M.V.
 2008
 18 Supplement 1 p. s16-
1 p.
 artikel
101 P.1.12 The neuroprotective effects of the group III metabotropic glutamate receptor agonist ACPT-1 in vitro and in vivo Domin, H.
 2008
 18 Supplement 1 p. s11-s12
nvt p.
 artikel
102 P.3.13 The niacin skin flush test in schizophrenia-a combined approach using laser doppler flowmetry and a visual rating scale Must, A.
 2008
 18 Supplement 1 p. s73-
1 p.
 artikel
103 P.4.02 Transforming growth factor-β1 (TGF-β1) signaling as a new pharmacological target against Aβ-induced neurodegeneration Caraci, F.
 2008
 18 Supplement 1 p. s86-s87
nvt p.
 artikel
104 Relationship between antidepressants and IGF-1 system in the brain: Possible role in cognition Grunbaum-Novak, Nurit
 2008
 18 Supplement 1 p. 431-438
8 p.
 artikel
105 S.20.03 β-Arrestin-dependent DAD2R/Akt/GSK3β signaling: relationship to mood stabilisers and antipsychotics Caron, M.G.
 2008
 18 Supplement 1 p. S184-
1 p.
 artikel
106 S.08.04 Cannabidiol as antipsychotic Leweke, F.M.
 2008
 18 Supplement 1 p. S171-
1 p.
 artikel
107 S.05.04 Cognition in mood disorders: from neuron to therapy Young, A.
 2008
 18 Supplement 1 p. S164-
1 p.
 artikel
108 S.26.01 Decision-making in animal models of opiate and stimulant addiction Ahmed, S.H.
 2008
 18 Supplement 1 p. S194-
1 p.
 artikel
109 S.06.02 Genetics of early onset in OCD Walitza, S.
 2008
 18 Supplement 1 p. S165-S166
2 p.
 artikel
110 S.03.03 Hypocretin/orexin modulation of sleep correlates in cortical network activity Broberger, C.
 2008
 18 Supplement 1 p. S159-
1 p.
 artikel
111 S.19.04 Is there a benefit in a combination treatment for Alzheimer's disease? Giacobini, E.
 2008
 18 Supplement 1 p. S183-
1 p.
 artikel
112 S.16.01 Neurogenesis in relation to aging and dementia Lucassen, P.J.
 2008
 18 Supplement 1 p. S178-
1 p.
 artikel
113 S.07.03 Transforming growth factor-β1 (TGF-β1) signaling as a new pharmacological target against Aβ-induced neurodegeneration Caraci, F.
 2008
 18 Supplement 1 p. S168-
1 p.
 artikel
114 S.22.05 Trauma-related disorders and suicide in the French WHO study “Santé Mentale en Population Générale” Jehel, L.
 2008
 18 Supplement 1 p. S188-
1 p.
 artikel
115 The CNR1 gene as a pharmacogenetic factor for antipsychotics rather than a susceptibility gene for schizophrenia Hamdani, Nora
 2008
 18 Supplement 1 p. 34-40
7 p.
 artikel
116 Therapeutic effects of Δ9-THC and modafinil in a marmoset Parkinson model van Vliet, Sanneke A.M.
 2008
 18 Supplement 1 p. 383-389
7 p.
 artikel
117 The triple monoaminergic reuptake inhibitor DOV 216,303 has antidepressant effects in the rat olfactory bulbectomy model and lacks sexual side effects Breuer, M.E.
 2008
 18 Supplement 1 p. 908-916
9 p.
 artikel
118 Time dependent alterations on tyrosine hydroxylase, opioid and cannabinoid CB1 receptor gene expressions after acute ethanol administration in the rat brain Oliva, José M.
 2008
 18 Supplement 1 p. 373-382
10 p.
 artikel
119 Variations in circulating cytokine levels during 52 week course of treatment with SSRI for major depressive disorder Hernández, María Eugenia
 2008
 18 Supplement 1 p. 917-924
8 p.
 artikel
120 8-week, single-blind, randomized trial comparing risperidone versus olanzapine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive–compulsive disorder Maina, Giuseppe
 2008
 18 Supplement 1 p. 364-372
9 p.
 artikel
                             120 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland